Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Multiple Sclerosis, Relapsing-Remitting × Fingolimod Hydrochloride × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Sclerosis 2 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Multiple Sclerosis, Relapsing-Remitting 1 Melanoma 1 Lymphopenia 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

teriflunomide 1 Vitamin D 1 Natalizumab 1 Fingolimod Hydrochloride 1 Dimethyl Fumarate 1 Cholecalciferol 1 Calcifediol 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06705608 2024-11-26

MS; FTY720

University of British Columbia

Carcinoma, Basal Cell, Melanoma, Multiple Sclerosis, Skin Neoplasms, Multiple Sclerosis, Relapsing-Remitting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡